Skip to content
healthcare.dev

PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release

NDC 69097-531, pantoprazole sodium granules, suspension, from Cipla USA Inc..

Product NDC
69097-531
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217458
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-531 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PANTOPRAZOLE SODIUM40 mg/1

Pharmacologic classes

Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
69097-531-536909705315330 PACKET in 1 CARTON (69097-531-53) / 1 SUSPENSION in 1 PACKET (69097-531-31)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/195e06db-b76c-4470-b6a5-a3979c25046d
  • NADAC price for package 69097053153

    GET /v1/drugs/nadac/69097053153

Use it

Look up 69097-531 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-531 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-531. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.